Alzheimer's disease Trials in Houston, United States
Conditions / Alzheimer's disease / Houston, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
51 total trials for this combination
Showing top 10 of 51 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05531526 | Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05617014 | Alzheimer's Disease Neuroimaging Initiative 4 | ENROLLING_BY_INVITATION | — |
| NCT04374253 | A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT00105547 | Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's | COMPLETED | PHASE3 |
| NCT06585787 | A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) | RECRUITING | — |
| NCT04619420 | A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03443973 | Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT05582200 | Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease | UNKNOWN | — |
| NCT04520412 | A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease | SUSPENDED | PHASE3 |